Joseph L Kuti

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 30

Top Venues

Journal of clinical microbiology

Pharmacotherapy

The Journal of antimicrobial chemotherapy

Antimicrobial agents and chemotherapy

Hartford Hospital

Rutgers University College of Pharmacy (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hartford Hospital Jul 01 2002

United States

Associate Director :: Center for Anti-Infective Research and Development

Education History

Rutgers University College of Pharmacy

United States

PHD

Publications

Andrew J Fratoni, Matthew L Gethers, David P Nicolau, Joseph L Kuti
Non-KPC Attributes of Newer β-lactam/β-lactamase Inhibitors, Part 1: Enterobacterales and Pseudomonas aeruginosa. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 79 (1) (2024)
Andrew J Fratoni, Matthew L Gethers, Yasmeen Abouelhassan, Joseph L Kuti
Non-KPC Attributes of Newer β-lactamase/β-lactamase Inhibitors, Part 1: Enterobacterales and Pseudomonas aeruginosa. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Christina Koenig, Joseph L Kuti
Evolving resistance landscape in gram-negative pathogens: An update on β-lactam and β-lactam-inhibitor treatment combinations for carbapenem-resistant organisms. Pharmacotherapy 44 (8) (2024)
Andrew J Fratoni, Abigail K Kois, Jason A Gluck, David P Nicolau, Joseph L Kuti
Imipenem/relebactam pharmacokinetics in critically ill patients supported on extracorporeal membrane oxygenation. The Journal of antimicrobial chemotherapy (2024)
Aliaa Fouad, Angela Berry, Jonathan Gates, Joseph L Kuti, Jane J Keating
Effect of Blood Product Resuscitation on Cefazolin Pharmacokinetics in Trauma Patients. Surgical infections (2024)
Yasmeen Abouelhassan, Joseph L Kuti, David P Nicolau, Kamilia Abdelraouf
Ampicillin-sulbactam against Acinetobacter baumannii infections: pharmacokinetic/pharmacodynamic appraisal of current susceptibility breakpoints and dosing recommendations. The Journal of antimicrobial chemotherapy (2024)
Yasmeen Abouelhassan, Joseph L Kuti, David P Nicolau, Kamilia Abdelraouf
Ampicillin-sulbactam against Acinetobacter baumannii infections: pharmacokinetic/pharmacodynamic appraisal of current susceptibility breakpoints and dosing recommendations. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Andrew J Fratoni, Matthew L Gethers, David P Nicolau, Joseph L Kuti
Non-KPC Attributes of Newer β-lactam/β-lactamase Inhibitors, Part 1: Enterobacterales and Pseudomonas aeruginosa. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 79 (1) (2024)
Christina Koenig, Joseph L Kuti
Evolving resistance landscape in gram-negative pathogens: An update on β-lactam and β-lactam-inhibitor treatment combinations for carbapenem-resistant organisms. Pharmacotherapy (2024)
Aliaa Fouad, Angela Berry, Jonathan Gates, Joseph L Kuti, Jane J Keating
Effect of Blood Product Resuscitation on Cefazolin Pharmacokinetics in Trauma Patients. Surgical infections 25 (6) (2024)
Andrew J Fratoni, Abigail K Kois, Jason A Gluck, David P Nicolau, Joseph L Kuti
Imipenem/relebactam pharmacokinetics in critically ill patients supported on extracorporeal membrane oxygenation. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Andrew J Fratoni, Abigail K Kois, Jason A Gluck, David P Nicolau, Joseph L Kuti
Imipenem/relebactam pharmacokinetics in critically ill patients supported on extracorporeal membrane oxygenation. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Andrew J Fratoni, Amity L Roberts, David P Nicolau, Joseph L Kuti
Effects of clinically achievable pulmonary antibiotic concentrations on the recovery of bacteria: in vitro comparison of the BioFire FILMARRAY Pneumonia Panel versus conventional culture methods in bronchoalveolar lavage fluid. Journal of clinical microbiology (2023)
Victor H Ruiz, Andrew Fratoni, David P Nicolau, Joseph L Kuti
In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis. Antimicrobial agents and chemotherapy (2023)
Andrew J Fratoni, Amity L Roberts, David P Nicolau, Joseph L Kuti
Effects of clinically achievable pulmonary antibiotic concentrations on the recovery of bacteria: in vitro comparison of the BioFire FILMARRAY Pneumonia Panel versus conventional culture methods in bronchoalveolar lavage fluid. Journal of clinical microbiology 62 (1) (2023)
Lisa T Hong, Kevin James Downes, Alireza FakhriRavari, Jacinda C Abdul-Mutakabbir, Joseph L Kuti, Sarah C J Jorgensen, David C Young, Mohammad H Alshaer, Matteo Bassetti, Robert A Bonomo, Mark Gilchrist, Soo Min Jang, Thomas P Lodise, Jason Alexander Roberts, Thomas Tängdén, Athena Zuppa, Marc H Scheetz
International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists. Pharmacotherapy 43 (8) (2023)
Lisa T Hong, Kevin James Downes, Alireza FakhriRavari, Jacinda C Abdul-Mutakabbir, Joseph L Kuti, Sarah C J Jorgensen, David C Young, Mohammad H Alshaer, Matteo Bassetti, Robert A Bonomo, Mark Gilchrist, Soo Min Jang, Thomas P Lodise, Jason Alexander Roberts, Thomas Tängdén, Athena Zuppa, Marc H Scheetz
International consensus recommendations for the use of prolonged-infusion beta-lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists: An executive summary. Pharmacotherapy 43 (8) (2023)
Andrew J Fratoni, Amity L Roberts, David P Nicolau, Joseph L Kuti
Effects of clinically achievable pulmonary antibiotic concentrations on the recovery of bacteria: in vitro comparison of the BioFire FILMARRAY Pneumonia Panel versus conventional culture methods in bronchoalveolar lavage fluid. Journal of clinical microbiology 62 (1) (2023)
Andrew J Fratoni, Amity L Roberts, David P Nicolau, Joseph L Kuti
Effects of clinically achievable pulmonary antibiotic concentrations on the recovery of bacteria: in vitro comparison of the BioFire FILMARRAY Pneumonia Panel versus conventional culture methods in bronchoalveolar lavage fluid. Journal of clinical microbiology 62 (1) (2023)
Andrew J Fratoni, Amity L Roberts, David P Nicolau, Joseph L Kuti
Effects of clinically achievable pulmonary antibiotic concentrations on the recovery of bacteria: in vitro comparison of the BioFire FILMARRAY Pneumonia Panel versus conventional culture methods in bronchoalveolar lavage fluid. Journal of clinical microbiology 62 (1) (2023)
Angela V Berry, Allison Conelius, Jason A Gluck, David P Nicolau, Joseph L Kuti
Cefiderocol is Not Sequestered in an Ex Vivo Extracorporeal Membrane Oxygenation (ECMO) Circuit. European journal of drug metabolism and pharmacokinetics (2023)
Andrew J Fratoni, Amity L Roberts, David P Nicolau, Joseph L Kuti
Effects of clinically achievable pulmonary antibiotic concentrations on the recovery of bacteria: in vitro comparison of the BioFire FILMARRAY Pneumonia Panel versus conventional culture methods in bronchoalveolar lavage fluid. Journal of clinical microbiology 62 (1) (2023)
Andrew J Fratoni, Amity L Roberts, David P Nicolau, Joseph L Kuti
Effects of clinically achievable pulmonary antibiotic concentrations on the recovery of bacteria: in vitro comparison of the BioFire FILMARRAY Pneumonia Panel versus conventional culture methods in bronchoalveolar lavage fluid. Journal of clinical microbiology 62 (1) (2023)
Andrew J Fratoni, Amity L Roberts, David P Nicolau, Joseph L Kuti
Effects of clinically achievable pulmonary antibiotic concentrations on the recovery of bacteria: in vitro comparison of the BioFire FILMARRAY Pneumonia Panel versus conventional culture methods in bronchoalveolar lavage fluid. Journal of clinical microbiology 62 (1) (2023)
Elaine Liu, Kristin E Linder, Joseph L Kuti
Antimicrobial Stewardship at Transitions of Care to Outpatient Settings: Synopsis and Strategies. Antibiotics (Basel, Switzerland) 11 (8) (2022)
Maxwell J Lasko, Matthew L Gethers, Jennifer L Tabor-Rennie, David P Nicolau, Joseph L Kuti
In Vitro Time-Kill Studies of Trimethoprim/Sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli Using Cation-Adjusted Mueller-Hinton Broth and ISO-Sensitest Broth. Antimicrobial agents and chemotherapy 66 (3) (2022)
Andrew J Fratoni, David P Nicolau, Joseph L Kuti
A guide to therapeutic drug monitoring of β-lactam antibiotics. Pharmacotherapy 41 (2) (2021)
Andrew J Fratoni, Jessica L Colmerauer, Kristin E Linder, David P Nicolau, Joseph L Kuti
A Retrospective Case Series of Concomitant Carbapenem and Valproic Acid Use: Are Best Practice Advisories Working? Journal of pharmacy practice (2021)
Maxwell J Lasko, Allison M Conelius, Oscar K Serrano, David P Nicolau, Joseph L Kuti
Impact of Intraoperative Cell Salvage on Concentrations of Antibiotics Used for Surgical Prophylaxis. Antimicrobial agents and chemotherapy 64 (12) (2020)
Iris H Chen, David P Nicolau, Joseph L Kuti
Imipenem/Cilastatin/Relebactam Alone and in Combination against Pseudomonas aeruginosa in the In Vitro Pharmacodynamic Model. Antimicrobial agents and chemotherapy 64 (12) (2020)

Joseph L Kuti.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Joseph L Kuti